These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21275429)
1. Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization. Zhang Z; Wriggers W Biochemistry; 2011 Mar; 50(12):2144-56. PubMed ID: 21275429 [TBL] [Abstract][Full Text] [Related]
2. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor. Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679 [TBL] [Abstract][Full Text] [Related]
3. Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation. Zhou M; Felder S; Rubinstein M; Hurwitz DR; Ullrich A; Lax I; Schlessinger J Biochemistry; 1993 Aug; 32(32):8193-8. PubMed ID: 8347619 [TBL] [Abstract][Full Text] [Related]
5. In-cell structural dynamics of an EGF receptor during ligand-induced dimer-oligomer transition. Kozer N; Clayton AHA Eur Biophys J; 2020 Jan; 49(1):21-37. PubMed ID: 31740999 [TBL] [Abstract][Full Text] [Related]
6. Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling. Pascarelli S; Merzhakupova D; Uechi GI; Laurino P J Biol Chem; 2021 Jul; 297(1):100872. PubMed ID: 34126069 [TBL] [Abstract][Full Text] [Related]
7. Two EGF molecules contribute additively to stabilization of the EGFR dimer. Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149 [TBL] [Abstract][Full Text] [Related]
8. Activation of the epidermal growth factor receptor: a series of twists and turns. Poger D; Mark AE Biochemistry; 2014 Apr; 53(16):2710-21. PubMed ID: 24697572 [TBL] [Abstract][Full Text] [Related]
9. Role of N-glycosylation in EGFR ectodomain ligand binding. Azimzadeh Irani M; Kannan S; Verma C Proteins; 2017 Aug; 85(8):1529-1549. PubMed ID: 28486782 [TBL] [Abstract][Full Text] [Related]
10. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237 [TBL] [Abstract][Full Text] [Related]
11. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation. Macdonald-Obermann JL; Pike LJ J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039 [TBL] [Abstract][Full Text] [Related]
12. Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope. Makabe K; Yokoyama T; Uehara S; Uchikubo-Kamo T; Shirouzu M; Kimura K; Tsumoto K; Asano R; Tanaka Y; Kumagai I Sci Rep; 2021 Mar; 11(1):5790. PubMed ID: 33707468 [TBL] [Abstract][Full Text] [Related]
14. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding. Taylor ES; Pol-Fachin L; Lins RD; Lower SK Proteins; 2017 Apr; 85(4):561-570. PubMed ID: 28019699 [TBL] [Abstract][Full Text] [Related]
15. A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor. Kohda D; Odaka M; Lax I; Kawasaki H; Suzuki K; Ullrich A; Schlessinger J; Inagaki F J Biol Chem; 1993 Jan; 268(3):1976-81. PubMed ID: 8420971 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050 [TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Jura N; Shan Y; Cao X; Shaw DE; Kuriyan J Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21608-13. PubMed ID: 20007378 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Alvarado D; Klein DE; Lemmon MA Cell; 2010 Aug; 142(4):568-79. PubMed ID: 20723758 [TBL] [Abstract][Full Text] [Related]